PD02-1: Modified dual time point 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma

PD02-2: MRE11 expression level predicts poor survival in upper tract urothelial carcinomas

PD02-3: Determination of PD-L1 expression in circulating tumor cells of clear cell renal cell carcinoma patients and correlation with response to PD-1 inhibitors

PD02-4: Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) in metastatic prostate cancer (PCa)

PD02-6: Renal arterial pseudoaneurysm after robotic-assisted partial nephrectomy: Single-center analysis of predictive factors